Stock listing
RVMD Stock Price, News, Filings & Events — Revolution Medicines, Inc.
Selected listing: RVMD · BOATS · USD · US
This page tracks Revolution Medicines, Inc.'s RVMD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RVMD:BOATS. RVMD:BOATS is the stock-level entry point for investors researching Revolution Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Revolution Medicines, Inc. is a public company traded under the ticker RVMD in the American market. With a market capitalization of approximately $40.2 billion, the company focuses on developing innovative therapies for cancer treatment. Its commitment to addressing unmet medical needs positions it as a key player in the biopharmaceutical industry.
- Ticker
- RVMD:BOATS
- Asset type
- Stock
- Market cap
- $43.68B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- BOATS
- Currency
- USD
Revolution Medicines, Inc. RVMD:BOATS stock context
This page tracks Revolution Medicines, Inc.'s RVMD:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RVMD:BOATS. RVMD:BOATS is the stock-level entry point for investors researching Revolution Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Revolution Medicines, Inc. is a public company traded under the ticker RVMD in the American market. With a market capitalization of approximately $40.2 billion, the company focuses on developing innovative therapies for cancer treatment. Its commitment to addressing unmet medical needs positions it as a key player in the biopharmaceutical industry.
Latest news from Revolution Medicines, Inc.
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
September 14, 2026
New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
September 2, 2026
U.S. FDA Approves Revolution Medicines' RASONQUE (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
August 27, 2026
U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
August 26, 2026
Revolution Medicines and BeOne Medicines Announce Clinical Development and Regional Commercialization Collaboration
August 11, 2026
Revolution Medicines, Inc. earnings calls
Revolution Medicines, Inc. (RVMD) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Revolution Medicines, Inc.
Revolution Medicines, Inc. investor report
Review AI stock analysis and investor report context for RVMD:BOATS.
Revolution Medicines, Inc. company profile
View the public company page for Revolution Medicines, Inc. on 6ix.
Revolution Medicines, Inc. news
Read company news and market updates connected to Revolution Medicines, Inc..
Revolution Medicines, Inc. investor events
Find investor webinars, events, and replay context for Revolution Medicines, Inc..
Alternate listings
RVMD:NASDAQ
US · USD
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
42Z:GETTEX
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
A2PYWG:LSX
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
1RVMD:MIL
IT · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
42Z:TRADEGATE
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
RVMD:BX
CH · CHF
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
A2PYWG:LS
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
RVMD:BMV
MX · MXN
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
42Z:DUS
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
42Z:FWB
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
42Z:HAM
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.
42Z:MUN
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is RVMD:BOATS.